UM

Browse/Search Results:  1-2 of 2 Help

Selected(0)Clear Items/Page:    Sort:
N-acetylcysteine for major mental disorders: a systematic review and meta-analysis of randomized controlled trials Journal article
Zheng, W., Zhang, Q. -E., Cai, D. -B., Yang, X. -H., Qiu, Y., Ungvari, G. S., Ng, C. H., Berk, M., Ning, Y. -P., Xiang, Y. -T.. N-acetylcysteine for major mental disorders: a systematic review and meta-analysis of randomized controlled trials[J]. ACTA PSYCHIATRICA SCANDINAVICA, 2018, 137(5), 391-400.
Authors:  Zheng, W.;  Zhang, Q. -E.;  Cai, D. -B.;  Yang, X. -H.;  Qiu, Y.; et al.
Favorite | TC[WOS]:65 TC[Scopus]:67  IF:5.3/6.6 | Submit date:2018/10/30
N-acetylcysteine  Oxidative Stress  Schizophrenia  Bipolar Disorder  Major Depressive Disorder  
Efficacy and safety of adjunctive topiramate for schizophrenia: a meta-analysis of randomized controlled trials Journal article
Zheng W., Xiang Y.-T., Xiang Y.-Q., Li X.-B., Ungvari G.S., Chiu H.F.K., Correll C.U.. Efficacy and safety of adjunctive topiramate for schizophrenia: a meta-analysis of randomized controlled trials[J]. Acta Psychiatrica Scandinavica, 2016, 134(5), 385-398.
Authors:  Zheng W.;  Xiang Y.-T.;  Xiang Y.-Q.;  Li X.-B.;  Ungvari G.S.; et al.
Favorite | TC[WOS]:41 TC[Scopus]:53 | Submit date:2018/12/18
Antipsychotic  Meta-analysis  Metabolic Abnormalities  Topiramate  Weight Gain